id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-D-2925-4519,FDA,FDA-2023-D-2925,Defining Durations of Use for Approved Medically Important Antimicrobial Drugs Fed to Food-Producing Animals; Guidance for Industry; #273; Final Guidance,Other,Guidance,2026-02-13T05:00:00Z,2026,2,2026-02-13T05:00:00Z,,2026-02-13T20:18:55Z,,1,0,09000064b91ab232
FDA-2023-D-2925-4518,FDA,FDA-2023-D-2925,Defining Durations of Use for Approved Medically Important Antimicrobial Drugs Fed to Food-Producing Animals; Guidance for Industry; Availability,Notice,Notice of Availability,2026-02-13T05:00:00Z,2026,2,,,2026-02-13T20:12:58Z,2026-02934,0,0,09000064b91aa7ca